Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Mar 10, 2010 8:57pm
302 Views
Post# 16868617

psa debate

psa debateCurrently the psa test is being debated on a daily basis in papers throughout the country. The psa market is $3 billion (wow), I have read powerful articles on both sides of the debate, but one thing is clear, a human life is worth saving. One article stated that they need to complete around 1100 screens and 48 treatments to save one life. Someone wrote in and said that their father passed away from prostate cancer when he was 50 years old without ever being screened for the disease. It will come down to individual physicians and how they will use the psa test.
     From all this it is clear that the PCA3 test is a solution to this debate, its a fit, and is a long over due answer to the physicians question. How do we proceed?

It has been a long time coming but PCA3 is going to hit this $3,000,000,000 market at the right time and help alot of people.
Bullboard Posts